← Back to Search

Supportive Care Intervention for Brain Cancer

N/A

Recruiting

Led By Deborah A Forst, MD

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

No Placebo-Only Group

Summary

This trial tests an intervention to help patients cope with a brain tumor diagnosis, including a guide & one-on-one coaching. Surveys & interviews measure its feasibility & acceptability.

Who is the study for?

This trial is for adults over 18 who are patients at Massachusetts General Hospital Cancer Center, recently diagnosed (within 6 weeks) with a primary malignant brain tumor and can speak and read English. It's not suitable for those unable to consent due to severe cognitive issues or if their oncologist thinks it's inappropriate.

What is being tested?

The study tests an information and support intervention designed to help brain tumor patients cope. It includes access to an info guide and one-on-one coaching sessions, assessing feasibility and acceptability through surveys and exit interviews.

What are the potential side effects?

Since this trial focuses on informational support rather than medication, traditional side effects aren't expected. However, participants may experience emotional or psychological responses related to discussing their condition.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Acceptability of the Intervention: Percentage of Participants who Have High Satisfaction with the Intervention

Feasibility of the Intervention: Percentage of Eligible Patients Who Enroll and Participate in the Intervention

Other study objectives

Exploratory: Coping

Exploratory: Distress (Depression and Anxiety Symptoms)

Exploratory: Loneliness

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: NeuroPathways Pilot RCTExperimental Treatment1 Intervention

Enrolled patients will receive an intervention guide with information about navigating life with a brain tumor diagnosis, and will participate in four weekly or biweekly, individual sessions with a clinician (e.g. nurse or behavioral health specialist). Participants will be asked to complete surveys at baseline, 8 weeks and 12 weeks.

Group II: NeuroPathways Open PilotExperimental Treatment1 Intervention

Group III: Usual supportive careActive Control1 Intervention

Participants will receive usual supportive care, which includes referral to cancer center supportive care services (e.g., social work) upon request from the patient, caregiver, or clinician. Participants will be asked to complete surveys at baseline, 8 weeks and 12 weeks.

Do I qualify?Apply below to find out